Brar Sheetal, Ganesh Sri, Rp Nikhil, Cr Roopashree
Department of Phaco-Refractive Surgery, Nethradhama Super Speciality Eye Hospital, Jayanagar, Bengaluru, Karnataka, 560070, India.
Clin Ophthalmol. 2021 Aug 3;15:3247-3257. doi: 10.2147/OPTH.S320202. eCollection 2021.
To evaluate the clinical outcomes and patient satisfaction after implantation of Optiflex Trio, a new trifocal intraocular lens (IOL) following cataract surgery.
Patients undergoing phacoemulsification for age-related cataracts and who satisfy the eligibility criteria underwent bilateral implantation with Optiflex Trio trifocal IOL. At follow -up visits of 1, 3, 6, and 12 months, binocular uncorrected and corrected distance, intermediate and near visual acuity, reading performance, contrast sensitivity (CS) and patient satisfaction for dysphotopsia and spectacle independence were evaluated using questionnaires.
A total of 54 eyes from 27 patients with mean age of 66.30±7.48 years were included in the study. At 12 months, 78% (n = 21) patients had binocular cumulative UDVA of 20/20 or better. Post-op SE refraction accuracy was within ±0.50 D for 93% (n = 50) eyes, and refractive cylinder accuracy was within ≤0.50 D in 94% (n = 51) eyes. The mean binocular UNVA was 0.01±0.05 LogMAR, and the mean UIVA at 60 and 80 cm was 0.07±0.06 and 0.03±0.05 LogMAR, respectively, at 12 months. Reading speeds at 40, 60 and 80 cm showed improvement overtime. No patient had complained of severe dysphotopsia, and none of the patients required glasses for any activity. No eye underwent YAG-laser capsulotomy for significant PCO at the end of mean follow-up.
After 12 months, Optiflex Trio trifocal IOL provided a complete visual restoration with good visual quality outcomes in terms of uncorrected distance, intermediate and near visual acuity. The incidence of dysphotopsia was low, and spectacle independence was high, resulting in good patient satisfaction.
CTRI/2019/10/021647 (www.ctri.nic.in).
评估白内障手术后植入新型三焦点人工晶状体（IOL）Optiflex Trio后的临床疗效和患者满意度。
因年龄相关性白内障接受超声乳化手术且符合入选标准的患者接受双侧Optiflex Trio三焦点IOL植入。在术后1、3、6和12个月的随访中，使用问卷评估双眼未矫正和矫正的远、中、近视力、阅读能力、对比敏感度（CS）以及患者对眩光和摆脱眼镜的满意度。
本研究共纳入27例患者的54只眼，平均年龄为66.30±7.48岁。在12个月时，78%（n = 21）的患者双眼累积未矫正远视力（UDVA）达到20/20或更好。术后球镜屈光度（SE）矫正精度在±0.50 D以内的眼占93%（n = 50），柱镜屈光度矫正精度在≤0.50 D以内的眼占94%（n = 51）。在12个月时，双眼平均未矫正近视力（UNVA）为0.01±0.05 LogMAR，在60 cm和80 cm处的平均未矫正中视力（UIVA）分别为0.07±0.06和0.03±0.05 LogMAR。在40 cm、60 cm和80 cm处的阅读速度随时间有所提高。没有患者抱怨严重眩光，且没有患者在任何活动中需要佩戴眼镜。在平均随访结束时，没有眼睛因明显的后囊膜混浊（PCO）而接受YAG激光后囊切开术。
12个月后，Optiflex Trio三焦点IOL在未矫正的远、中、近视力方面提供了良好的视觉质量结果，实现了完全的视力恢复。眩光发生率低，摆脱眼镜的比例高，患者满意度良好。
CTRI/2019/10/021647（www.ctri.nic.in）。
